The Council for Responsible Nutrition (CRN), a leading trade
association for the dietary supplement industry, announced in August that its
members have recently agreed to follow voluntary guidelines for the responsible
marketing of dehydroepiandrosterone (DHEA).1 These new guidelines
specify that CRN members will not market DHEA products as being able to provide
a general anabolic steroid-like response (such as muscle enlargement or
increased strength) and not target consumers under the age of 18 in their
marketing or advertisements for DHEA products.
DHEA is a naturally occurring steroid hormone produced by the
adrenal glands that serves as an indirect precursor to estrogen and
testosterone.2 It is not an anabolic steroid, and its use is not
associated with the adverse side effects often caused by anabolic steroid
abuse. DHEA levels decline rapidly with age, and DHEA supplementation has been
show to restore these levels and provide other health benefits in older adults
or patients with endocrine deficiencies. DHEA in dietary supplements is
typically derived from wild yam (Dioscorea
spp.).3
“This is an important step forward in self-regulation by the
dietary supplement industry, and we encourage other companies to join our
members in following these guidelines,” said CRN President and CEO Steve Mister,
in a recent CRN press release about the new voluntary DHEA marketing program.1
“It’s disturbing to see some of the ads in magazines or online that promote
DHEA as if it were a drug or anabolic steroid, when the fact is existing
research has not demonstrated that kind of effect. Advertising that
over-promises results leads to consumer confusion and casts a negative shadow
over the entire industry.”
In 2004, the Anabolic Steroid Control Act was signed into
law, placing several steroid precursors—excluding DHEA—on the Controlled
Substances List.3 Recognizing that DHEA does not act as a
performance-enhancing substance in the same manner as anabolic steroids and is
not subject to abuse, addiction or adverse side effects associated with
anabolic steroid compounds, Congress specifically and intentionally omitted
DHEA from that list. Many herb and dietary supplement trade associations, in
addition to healthcare and professional athletics organizations, supported this
Act, which was introduced by Senators Orrin Hatch (R-UT) and Joe Biden (D-DE).
In December of 2007, Senators Charles Grassley (R-IA) and Charles E. Schumer
(D-NY) introduced a bill that proposes to amend the Controlled Substances Act
to prevent access of DHEA to minors and create penalties for those providing
DHEA to minors.4 CRN publicly opposed the introduction of this bill,
arguing that such measures are unnecessary, would do nothing to address problems
associated with anabolic steroid use, and could negatively impact the
availability of DHEA for those consumers interested in its documented
beneficial health uses.
“There is no evidence that DHEA is being abused by minors nor
is there evidence that DHEA works as a performance-enhancing product in young
healthy adults. Restricting the access of DHEA would set an unacceptable
precedent and would create the misimpression that DHEA deserves to be hidden
behind the counter,” Mister said in a CRN statement in December 2007.4
CRN’s voluntary guidelines for the marketing of DHEA instead reinforce
self-regulatory efforts within the industry.
According to CRN, DHEA has been on the market for more than
20 years. In older adults with compromised hormone level production, DHEA
supplements have shown possible benefits in helping to support immune function,
maintain cognitive function and elevate mood, improve sleep patterns, maintain
strong bones, and normalize glucose metabolism.1,2 Long-term
controlled studies at varying doses have demonstrated its safety, with no
adverse side effects associated with its use.
—Courtney Cavaliere
References
1.
CRN adopts
voluntary program for marketing DHEA [press release]. Washington DC:
Council for Responsible Nutrition; August 4, 2008.
2.
Shao A. DHEA:
the basic facts [backgrounder]. Washington
DC: Council for Responsible
Nutrition.
3.
Blumenthal M.
President signs new law banning designer steroids dietary supplements: DHEA
exempted from ban. HerbalGram. 2005;65:58-59.
4.
Council for
Responsible Nutrition calls proposed DHEA legislation ‘a solution in search of
a problem’ [press release]. Washington DC: Council for
Responsible Nutrition; December 18, 2007.
|